ebomi
Colour theme
Sign in
Insider · CIK 0001307729

Baker Brothers Life Sciences Capital (Gp), LLC

CIK 0001307729 Name as filed on the most recent filing

Filed as Baker Brothers Life Sciences Capital (Gp), LLC (174)· Baker Biotech Capital III (Gp), LLC (12)

647 transaction lines · from 186 filings · filed 2005-02-14 to 2012-03-14 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2007-03-09 P, Open-market purchase Genomic Health IncGHDX 2 lines 3,081,430, acquired Open Form 4 filing 0001144204-07-012456
2007-03-02 P, Open-market purchase Genomic Health IncGHDX 137,056, acquired Open Form 4 filing 0001144204-07-011195
2007-03-01 P, Open-market purchase Genomic Health IncGHDX 3 lines 831,454, acquired Open Form 4 filing 0001144204-07-011195
2007-02-16 P, Open-market purchase Genomic Health IncGHDX 2 lines 471,155, acquired Open Form 4 filing 0001144204-07-009442
2007-02-14 S, Open-market sale Seattle Genetics Inc /WASGEN 14,014,178, disposed Open Form 4 filing 0001144204-07-008819
2007-02-14 S, Open-market sale Seattle Genetics Inc /WASGEN 13,950,186, disposed Open Form 4 filing 0001144204-07-008783
2007-02-14 P, Open-market purchase Genomic Health IncGHDX 2 lines 1,291,452, acquired Open Form 4 filing 0001144204-07-008310
2007-02-13 P, Open-market purchase Genomic Health IncGHDX 3,048,309, acquired Open Form 4 filing 0001144204-07-008310
2007-02-12 P, Open-market purchase Genomic Health IncGHDX 389,019, acquired Open Form 4 filing 0001144204-07-008310
2007-01-29 P, Open-market purchase Allos Therapeutics IncALTH 14,045,868, acquired Open Form 4 filing 0001144204-07-004794
2007-01-25 P, Open-market purchase Ardea Biosciences, Inc./DEIBPI 212,814, acquired Open Form 4 filing 0001144204-07-003652
2007-01-24 P, Open-market purchase Ardea Biosciences, Inc./DEIBPI 70,897, acquired Open Form 4 filing 0001144204-07-003652
2007-01-11 P, Open-market purchase Ardea Biosciences, Inc./DEIBPI 299,833, acquired Open Form 4 filing 0001144204-07-001494
2007-01-10 P, Open-market purchase Ardea Biosciences, Inc./DEIBPI 85,660, acquired Open Form 4 filing 0001144204-07-001494
2007-01-09 P, Open-market purchase Ardea Biosciences, Inc./DEIBPI 118,733, acquired Open Form 4 filing 0001144204-07-001494
2006-12-26 P, Open-market purchase Intrabiotics Pharmaceuticals Inc /DEIBPI 331,992, acquired Open Form 4 filing 0001144204-06-054649
2006-12-22 P, Open-market purchase Intrabiotics Pharmaceuticals Inc /DEIBPI 595,557, acquired Open Form 4 filing 0001144204-06-054649
2006-12-06 P, Open-market purchase Genomic Health IncGHDX 737,532, acquired Open Form 4 filing 0001144204-06-051881
2006-12-05 P, Open-market purchase Genomic Health IncGHDX 1,578,459, acquired Open Form 4 filing 0001144204-06-051344
2006-12-04 P, Open-market purchase Genomic Health IncGHDX 2 lines 691,446, acquired Open Form 4 filing 0001144204-06-051344
2006-12-01 P, Open-market purchase Genomic Health IncGHDX 5 lines 7,705,696, acquired Open Form 4 filing 0001144204-06-051344
2006-11-28 P, Open-market purchase Allos Therapeutics IncALTH 1,184,200, acquired Open Form 4 filing 0001144204-06-050783
2006-11-17 P, Open-market purchase Allos Therapeutics IncALTH 471,321, acquired Open Form 4 filing 0001144204-06-049248
2006-11-16 P, Open-market purchase Allos Therapeutics IncALTH 641,528, acquired Open Form 4 filing 0001144204-06-049248
2006-11-15 P, Open-market purchase Allos Therapeutics IncALTH 1,856,016, acquired Open Form 4 filing 0001144204-06-049248
2006-09-08 P, Open-market purchase Genomic Health IncGHDX 2 lines 2,832,727, acquired Open Form 4 filing 0001144204-06-037866
2006-09-07 P, Open-market purchase Genomic Health IncGHDX 500,916, acquired Open Form 4 filing 0001144204-06-037866
2006-08-14 P, Open-market purchase Seattle Genetics Inc /WASGEN 150,134, acquired Open Form 4 filing 0001144204-06-034238
2006-08-11 P, Open-market purchase Seattle Genetics Inc /WASGEN 429,591, acquired Open Form 4 filing 0001144204-06-033663
2006-08-10 P, Open-market purchase Seattle Genetics Inc /WASGEN 2 lines 14,503, acquired Open Form 4 filing 0001144204-06-033663
2006-08-09 P, Open-market purchase Seattle Genetics Inc /WASGEN 2 lines 791,152, acquired Open Form 4 filing 0001144204-06-033664
2006-08-09 P, Open-market purchase Seattle Genetics Inc /WASGEN 2 lines 791,152, acquired Open Form 4 filing 0001144204-06-032177
2006-08-08 P, Open-market purchase Seattle Genetics Inc /WASGEN 30,010, acquired Open Form 4 filing 0001144204-06-033664
2006-08-08 P, Open-market purchase Seattle Genetics Inc /WASGEN 30,010, acquired Open Form 4 filing 0001144204-06-032177
2006-08-07 P, Open-market purchase Seattle Genetics Inc /WASGEN 115,746, acquired Open Form 4 filing 0001144204-06-033659
2006-08-07 P, Open-market purchase Seattle Genetics Inc /WASGEN 115,746, acquired Open Form 4 filing 0001144204-06-031420

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Baker Brothers Life Sciences Capital (GP), LLC, insider transactions. Retrieved 2026-08-28 from https://ebomi.com/insider/0001307729

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.